[Nicotinic receptor polymorphism amplifies cigarette smoke-induced inflammation in COPD, a silent epidemic].

Authors

L Massara, G Kervoaze, A Ollivier, M Pichavant, L Saber-Cherif, S Pons, U Maskos, V Dormoy, P Gosset

Published in

Revue des maladies respiratoires. Sep 28, 2026. Epub Sep 28, 2026.

Abstract

Chronic obstructive pulmonary disease (COPD) is the third leading cause of mortality and morbidity. Recent studies on genetic polymorphism highlight the CHRNA5/3/B4 locus, coding for nicotinic subunit receptors such as rs16969968 polymorphism (α5SNP), as genetic determinants of pulmonary vulnerability, acting independently of smoking intensity. We have demonstrated that altered α5 nicotinic receptor expression influences epithelial differentiation, promotes inflammation, and drives airway remodeling. These findings point to a functional role of the pulmonary nicotinic system in COPD pathogenesis and underline the need for precision medicine approaches combining genetic, environmental, and clinical markers so as to better predict disease risk and develop relevant preventive strategies.

PMID:
42805833
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.